Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |